Weekly docetaxel versus CMF as adjuvant chemotherapy for older women with early breast cancer: final results of the randomized phase III ELDA trialFrancesco Perrone, A. De Matteis, Francesco Nuzzo et al.|Annals of Oncology|2014Cited by 68
Vinorelbine plus 3-weekly trastuzumab in metastatic breast cancer: a single-centre phase 2 trialErmelinda De Maio, A. De Matteis, Adriano Gravina et al.|BMC Cancer|2007Cited by 26
Evaluation of TAG-72 as a serum marker in ovarian and breast carcinoma.Gennaro Esposito, Marco Salvatore, N. Panza et al.|PubMed|1991Cited by 3
P920. Breast cancer with more than 3 positive nodes: adjuvant epirubicin followed by CMF +/- hormonotherapy. Preliminary resultsA. De Matteis, Alfonso Maiorino, G.D.' Aiuto et al.|The Breast|1997Cited by 0